Nephrotic syndrome after norfloxacin.
B
B
Hanson
A
A
D'Hondt
M
M
Depierreux
F
F
Lustman
D000368:Aged; D017311:Amlodipine / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007548:Isosorbide Dinitrate / Q000627:therapeutic use; D017706:Lisinopril / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D009643:Norfloxacin / Q000009:adverse effects*; D011507:Proteinuria; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000890:Anti-Infective Agents; D000959:Antihypertensive Agents; D004232:Diuretics; D017311:Amlodipine; D005665:Furosemide; D003404:Creatinine; D017706:Lisinopril; D007548:Isosorbide Dinitrate; D003000:Clonidine; D009643:Norfloxacin; D007213:Indomethacin